Incyte Corp.
Key Metrics
Market Snapshot
About
Incyte Corp. is a biopharmaceutical company focused on discovering, developing, and commercializing proprietary therapeutics for serious unmet medical needs. The company's marketed products include Jakafi for myelofibrosis and polycythemia vera, Pemazyre for cholangiocarcinoma, and Opzelura for atopic dermatitis and vitiligo. Incyte maintains a diverse pipeline of oncology and inflammation programs built around novel mechanisms including JAK inhibitors, FGFR inhibitors, and immuno-oncology approaches. The company combines internal drug discovery expertise with strategic collaborations to advance multiple therapeutic candidates across various disease areas.